Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up-Reference-Cited by-同舟云学术

Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up

Published:2013-01 Issue:1 Volume:18 Page:8-13
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Ejerblad Elisabeth¹,Kvasnicka Hans M.²,Thiele Jürgen²,Andreasson Björn³,Björkholm Magnus⁴,Löfvenberg Eva⁵,Markevärn Berit⁶,Merup Mats⁵,Nilssson Lars⁷,Palmblad Jan⁵,Samuelsson Jan⁸,Birgegård Gunnar¹

Affiliation:

1. Department of Hematology, Uppsala University, Sweden

2. Institution of PathologyUniversity of Cologne, Germany

3. Section of Hematology and CoagulationSahlgrenska University Hospital, Gothenburg, Sweden

4. Hematology CenterKarolinska University Hospital, Solna, Sweden

5. Hematology CenterKarolinska University Center, Huddinge, Sweden

6. Department of MedicineUniversity Hospital, Umeå, Sweden

7. Department of HematologyUniversity Hospital, Lund, Sweden

8. Department of Medicine, Stockholm South Hospital, Sweden

Publisher

Informa UK Limited

Subject